http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-102013017846-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e59b998e6094659c8f60253b48f1eca1 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate | 2013-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4adf3b1a2c9a1cb3cc6a4197eed6090 |
| publicationDate | 2015-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BR-102013017846-A2 |
| titleOfInvention | Ultraconcentrated active nanoformulations and submicroformulations with antispasmodic dendrimers and / or aines (non-hormonal anti-inflammatory drugs) and / or antihistamines or aies (anti-inflammatory hormones) and / or cyclosporins for the purpose of redeeming symptoms of inflammation, colic, itching and pain in cattle, swine, goats, sheep, canines and felines or benzoyl urea and / or acyl urea and / or avermectins alone or combined with vermifuge and / or insecticides for the control and prevention of endo and ectoparasites in cattle, pigs, goats, sheep, canines, felines and birds |
| abstract | Ultra-concentrated nanoformulations and submicroformulations with antispasmodic dendrimers and / or aines (non-hormonal antiinflammatory drugs) and / or antihistamines or aies (anti-inflammatory hormones) and / or cyclosporins for the purpose of redeeming symptoms of inflammation, colic, itching and pain in cattle, swine, goats, sheep, canines and felines or benzoyl urea and / or acyl urea and / or avermectins alone or combined with vermifuge and / or insecticides for the control and prevention of endo and ectoparasites in cattle, swine, goats, sheep, canines, felines and poultry. "Patent of the invention pertaining to the field of veterinary drugs comprising possible combinations claimed for their respective actives, preservatives, solvents, co-solvents, stabilizers, fixed oils and their derivatives and excipients The therapeutic dose ranges of each formulation will take into account body weight, target species and target parasite. The routes used will be topical (pour-on), injectable (intramuscular, deep intramuscular, subcutaneous, intravenous and atrial subcutaneous) and subdermal implants. |
| priorityDate | 2013-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 206.